Patricia LoRusso, D.O.

Cybrexa Scientific Advisor

Patricia M. LoRusso, is the associate director for experimental therapeutics at Yale University. Dr. LoRusso is also the Principal Investigator of the National Cancer Institute/Clinical Trials Evaluation Program (NCI/CTEP) Early Therapeutics UM1 Grant for Yale University, overseeing 4 additional NCI designated cancer center UM1 programs. She brings more than 25 years of expertise in medical oncology, drug development, and early phase clinical trials. Prior to her Yale appointment, she served in numerous leadership roles at Wayne State University’s Barbara Karmanos Cancer Institute, most recently as director of the Phase I Clinical Trials Program and of the Eisenberg Center for Experimental Therapeutics. Dr. LoRusso serves on the Board of Directors for the American Association of Cancer Research and serves on the Board of Scientific Council for the National Cancer Institute (NCI) Intramural Program. Dr. LoRusso has served as co-chair of the NCI Cancer Therapy Evaluation Program (CTEP) Investigational Drug Steering Committee. She has also served on the education and scientific committees of the American Society of Clinical Oncology (ASCO), the scientific committee of the American Association for Cancer Research (AACR), and as a parent member of the NCI’s Quick Trials Clinical Subcommittee. She has served either ad hoc or as an appointed member on multiple study sections, including Subcommittee D of the Program Projects Grants, and Small Business Innovation Research (SBIR) and Department of Defense (DOD) study sections. She has reviewed for Komen Promise grants, numerous SPORE and P01 study sections and translational research grants.


5 Science Park 395 Winchester Ave. New Haven, CT 06511 (860) 717-2731